Protective and toxic roles of dopamine in Parkinson's disease.
about
Degeneration of Dopaminergic Neurons Due to Metabolic Alterations and Parkinson's DiseaseRedox Imbalance and Viral Infections in Neurodegenerative DiseasesOxidative stress and Parkinson's diseaseToxoplasma gondii-induced neuronal alterationsNeuroprotective Effects of Salidroside in the MPTP Mouse Model of Parkinson's Disease: Involvement of the PI3K/Akt/GSK3β PathwayInteractions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's diseaseFormation and Biological Targets of Quinones: Cytotoxic versus Cytoprotective EffectsNorepinephrine and its metabolites are involved in the synthesis of neuromelanin derived from the locus coeruleusCovalent Modifiers: A Chemical Perspective on the Reactivity of α,β-Unsaturated Carbonyls with Thiols via Hetero-Michael Addition ReactionsPost translational changes to α-synuclein control iron and dopamine trafficking; a concept for neuron vulnerability in Parkinson's disease.Kinase-dependent Regulation of Monoamine Neurotransmitter Transporters.Quinone-induced protein handling changes: implications for major protein handling systems in quinone-mediated toxicityA dopamine receptor contributes to paraquat-induced neurotoxicity in Drosophila.The N-terminal residues 43 to 60 form the interface for dopamine mediated α-synuclein dimerisation.Proteomics in neurodegenerative diseases: Methods for obtaining a closer look at the neuronal proteome.Lack of Neuronal IFN-β-IFNAR Causes Lewy Body- and Parkinson's Disease-like DementiaDT-Diaphorase Prevents Aminochrome-Induced Alpha-Synuclein Oligomer Formation and Neurotoxicity.Chronic Nicotine Mitigates Aberrant Inhibitory Motor Learning Induced by Motor Experience under Dopamine Deficiency.Mic60/mitofilin overexpression alters mitochondrial dynamics and attenuates vulnerability of dopaminergic cells to dopamine and rotenone.The Atypical MAP Kinase SWIP-13/ERK8 Regulates Dopamine Transporters Through a Rho-Dependent Mechanism.DT-diaphorase Protects Against Autophagy Induced by Aminochrome-Dependent Alpha-Synuclein Oligomers.Harnessing the trophic and modulatory potential of statins in a dopaminergic cell line.Aminochrome Toxicity is Mediated by Inhibition of Microtubules Polymerization Through the Formation of Adducts with Tubulin.Melanin and neuromelanin binding of drugs and chemicals: toxicological implications.Glutathione transferase-M2-2 secreted from glioblastoma cell protects SH-SY5Y cells from aminochrome neurotoxicity.l-DOPA-induced dyskinesia and neuroinflammation: do microglia and astrocytes play a role?Commentary: Evaluation of Models of Parkinson's Disease.On the role of endogenous neurotoxins and neuroprotection in Parkinson's disease.Brain and Peripheral Atypical Inflammatory Mediators Potentiate Neuroinflammation and Neurodegeneration.A new mechanism for protection of dopaminergic neurons mediated by astrocytes.Is Alpha-Synuclein Loss-of-Function a Contributor to Parkinsonian Pathology? Evidence from Non-human Primates.Commentary: Gene Therapy: A Promising Approach for Neuroprotection in Parkinson's Disease?Aminochrome as preclinical model for Parkinson's disease.Aminochrome induces dopaminergic neuronal dysfunction: a new animal model for Parkinson's disease.Commentary: A Humanized Clinically Calibrated Quantitative Systems Pharmacology Model for Hypokinetic Motor Symptoms in Parkinson's Disease.Neurotoxin mechanisms and processes relevant to Parkinson's disease: an update.Neuromelanin in Parkinson's Disease: from Fenton Reaction to Calcium Signaling.Elucidation of the interplay between Fe(II), Fe(III), and dopamine with relevance to iron solubilization and reactive oxygen species generation by catecholamines.iPS cells in the study of PD molecular pathogenesis.Bioactivity of Olive Oil Phenols in Neuroprotection.
P2860
Q26750370-1420CCD0-D2FC-4882-B9D5-0E766C101F99Q26750630-5470CF67-667A-4C64-B4E5-F066B5A2F164Q26798897-3A18AF0D-58A1-4C6E-A7E3-0076D0B74B63Q27027025-EFB24588-CF13-40C8-AF50-44D3F9FDE11CQ28390865-462EC8DC-FE5F-4AFC-8CF7-ADA0477DBED9Q28391762-3A67B619-51F4-4DA6-9832-B9F9C10E6060Q28468284-8E2E21D0-2C74-4BBD-82A3-E5E25260D7ABQ28831116-B1D6EC24-E196-41F6-A85B-D79C0F2625FCQ29248430-51E8139B-6899-4BF1-84F6-92FE6F0CB001Q33776138-066321EC-5552-4457-B99D-A6926518B4F8Q34161514-995EF097-FEC8-44C1-BE71-756157382B1DQ35032377-9F8409DF-E1CB-454B-B8F9-97EB6CEC87D0Q35078638-CE44FED2-1B8B-4A1C-B7D0-14BCBDC43C5EQ35094912-3DCBC301-7779-4521-BB13-F778B0DE29FAQ35241298-6B844E77-6A54-4226-B0BD-0CFD2DEC12A6Q36146776-83E2A898-29A8-4257-BF74-ED70026EB637Q36801715-2D3E68C7-3E4C-4D04-B42B-77C4C945A4A6Q36889608-4782D2DF-B67C-4A17-BC9F-9BBCC24F0366Q37631968-F5F83CE5-AF17-41BB-9CA8-5A2F981CF703Q38429066-2A0BCA33-A039-44C4-9FCF-53D7829D1A0DQ38704492-87382CE6-4ECE-489C-A368-E446A8DDDC0EQ38809645-56A4EF11-C360-4DE7-A8FB-A03F0B5ED67FQ38837288-08B47AF4-EE1A-40E5-BA0E-1E4280112B04Q38867426-8C7AAF7E-227F-4E57-B3C2-F884649DC267Q38939870-8B4026CA-5E4D-4961-BDFA-AE3217342948Q39012371-988FC6B5-447E-4714-A0BB-D722DDEA0936Q40307796-7506E69B-C5D3-4702-B353-094CD479482AQ41043688-C9E9FB6C-686A-42C2-AFCB-6E1B6227AD8FQ41097407-F371EF1A-85B0-4E7B-8F62-2A4B9E2958E5Q41521497-A603B2D7-BFEA-4DB4-A5BE-C798FCBC240DQ41837003-DDD1DA23-79B5-407D-8059-DA6FA2D8FD1EQ42257009-E34AD31B-6CC1-4D04-B0EF-8B59CFBB59ECQ42341758-A09E0433-75D8-4FCB-BBAA-1DC32C1C6D66Q42490819-0E87B103-2F40-43FF-9B86-29008E03441FQ42615002-78580D92-B30F-4B9E-97CC-EF379D80856FQ43679571-80711FD2-D230-4C1F-BB4A-392944D3F208Q46311037-46F6443C-91CF-4534-9F2D-0D456F51672DQ46577527-E921F5F9-1960-4848-AAB4-4BA65B96D038Q46579323-A3E39061-1345-4212-8D5D-209EDD80933CQ47099956-B4C51F44-28D5-4260-94DC-598DED0449D0
P2860
Protective and toxic roles of dopamine in Parkinson's disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Protective and toxic roles of dopamine in Parkinson's disease.
@en
type
label
Protective and toxic roles of dopamine in Parkinson's disease.
@en
prefLabel
Protective and toxic roles of dopamine in Parkinson's disease.
@en
P2860
P50
P356
P1476
Protective and toxic roles of dopamine in Parkinson's disease.
@en
P2093
Luigi Zecca
Patricia Muñoz
P2860
P304
P356
10.1111/JNC.12686
P407
P577
2014-03-18T00:00:00Z